Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review

Canna Clinical TrialsLeave a comment

Medicinal cannabis has received increased research attention over recent years due to loosening global regulatory changes. Medicinal cannabis has been reported to have potential efficacy in reducing pain, muscle spasticity, chemotherapy-induced nausea and vomiting, and intractable childhood epilepsy. Yet its potential application in the field of psychiatry is lesser known. There is currently encouraging, albeit embryonic, evidence for medicinal cannabis in the treatment of a range of psychiatric disorders.
Supportive findings are emerging for some key isolates, however, clinicians need to be mindful of a range of prescriptive and occupational safety considerations, especially if initiating higher dose THC formulas.

Researchers Learn How to Improve Medical Cannabis Plant Production

Cannabis news, Medical NewsLeave a comment

University of Guelph researchers have published what is believed to be the first scientific paper in North America on improving medicinal cannabis plant production, helping move the industry into the realm of high-tech laboratories and evidence-based practices. “Growing marijuana has been illegal for so many years that there has been hardly any scientific research up…

Efficacy and Tolerability of Phytomedicines in Multiple Sclerosis Patients: A Review

Canna Clinical TrialsLeave a comment

Multiple sclerosis (MS) is a chronic inflammatory and demyelinating disorder of the central nervous system (CNS) that can cause cognition, mobility, and sensory impairments. It is considered one of the most common non-traumatic causes of disability in the world. The aim of the present article was to review the clinical evidence related to medicinal plants in the management of MS symptoms.